A. K. Atta, T. Pathak
FULL PAPER
pressure, and the residue was poured into saturated aq. NaHCO3
solution. The aqueous part was washed with EtOAc (3ϫ20 mL).
The combined organic layer was dried with anhyd. Na2SO4 and
filtered; the filtrate was concentrated under reduced pressure. The
residue was dissolved in dry MeOH (15 mL), and magnesium mon-
operoxyphthalate hexahydrate (0.98 g, 1.98 mmol) was added. Af-
ter 5 h, MeOH was removed under reduced pressure, and the resi-
due was poured into saturated aq. NaHCO3 solution. The aqueous
part was washed with EtOAc (3ϫ20 mL). The combined organic
layer was dried with anhyd. Na2SO4 and filtered; the filtrate was
concentrated under reduced pressure. The residue was purified over
silica gel to afford 12 (0.18 g, 65%). White liquid, [α]2D4 = +24.7 (c
= 0.16, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 2.42 (s, 3 H),
3.37–3.53 (m, 3 H), 3.83 (d, J = 4.4 Hz, 2 H), 4.05–4.11 (m, 1 H),
4.40–4.54 (m, 4 H), 4.77 (t, J = 6.4 Hz, 1 H), 7.10 (d, J = 3.6 Hz,
2 H), 7.26–7.35 (m, 10 H), 7.74 (d, J = 8.0 Hz, 2 H) ppm. 13C
NMR (100 MHz, CDCl3): δ = 21.7, 50.2 (CH2), 62.9 (CH2), 63.0,
64.7, 73.2 (CH2), 73.9 (CH2), 74.4, 127.8, 127.9, 128.0, 128.3, 128.5,
128.7, 130.3, 134.3, 136.2, 137.1, 146.0 ppm. HRMS (ES+): calcd.
for C26H28O6S2Na [M + Na]+ 523.1225; found 523.1217.
57.0, 66.8, (CH2) 67.0, 72.5 (CH2), 73.4 (CH2), 74.1 (CH2), 76.0,
78.4, 115.0, 117.0, 127.6 (2ϫC), 127.9, 128.0 (2ϫC), 128.1, 128.3,
128.4, 128.5, 130.4, 136.0, 137.1, 137.3, 137.4, 145.8 ppm. HRMS
(ES+): calcd. for C37H36N2O5SNa [M + Na]+ 643.2242; found
643.2242.
Compound 17: Compound 13 (0.22 g, 0.338 mmol) was converted
to 17 (0.14 g, 73%) by following the procedure described for the
preparation of 6. Colorless oil, [α]2D7 = –0.86 (c = 0.40, CHCl3). 1H
NMR (400 MHz, CDCl3): δ = 2.43 (s, 3 H), 3.15 (dd, J = 7.2,
11.6 Hz, 1 H), 3.24 (t, J = 6.0 Hz, 1 H), 3.32 (dd, J = 8.4, 11.2 Hz,
1 H), 3.46 (dd, J = 5.2, 10.0 Hz, 1 H), 3.55 (dd, J = 3.6, 10.0 Hz,
1 H), 3.72–3.77 (m, 1 H), 3.86 (q, J = 4.8, 10.8 Hz, 1 H), 4.24 (d,
J = 11.6 Hz, 1 H), 4.36–4.39 (m, 2 H), 4.44–4.53 (m, 3 H), 4.68 (d,
J = 11.2 Hz, 1 H), 7.19–7.36 (m, 17 H), 7.74 (d, J = 8.4 Hz, 2 H)
ppm. 13C NMR (100 MHz, CDCl3): δ = 21.6, 46.5 (CH2), 63.9,
70.2, 70.3 (CH2), 71.2 (CH2), 73.0 (CH2), 73.3 (CH2), 77.9, 79.4,
127.5, 127.6, 127.7, 127.8, 128.1, 128.2, 128.3, 128.4 (2ϫC), 130.0,
135.3, 137.1, 138.1, 138.6, 145.0 ppm. HRMS (ES+): calcd. for
C34H38NO5S [M + H]+ 572.2471; found 572.2438.
Compound 18: Method A: Compound 13 (0.25 g, 0.38 mmol) was
converted to 18 (0.191 g, 85%) by following the procedure de-
scribed for the preparation of 7. White oil, [α]2D7 = +86.7 (c = 0.40,
Compound 14: Compound 13 (0.20 g, 0.37 mmol) was converted
to 14 (0.139 g, 66%) by following the procedure described for the
preparation of 2. White liquid, [α]2D4 = +52.9 (c = 0.33, CHCl3). IR
1
CHCl3). H NMR (400 MHz, CDCl3): δ = 2.39 (s, 3 H), 2.45 (s, 3
(CHCl ): ν = 1086, 1147, 1257, 1654, 1725, 1736 cm–1. 1H NMR
˜
3
H), 2.59–2.64 (m, 1 H), 2.76 (t, J = 5.6 Hz, 1 H), 3.27 (t, J =
8.8 Hz, 1 H), 3.60–3.70 (m, 2 H), 3.80–3.85 (m, 1 H), 3.88–3.91 (m,
1 H), 4.28 (d, J = 11.6 Hz, 1 H), 4.39 (d, J = 12.0 Hz, 1 H), 4.43–
4.48 (m, 3 H), 4.56 (d, J = 11.2 Hz, 1 H), 4.73 (d, J = 11.6 Hz, 1
H), 7.19–7.21 (m, 2 H), 7.28–7.38 (m, 15 H), 7.76 (d, J = 8.4 Hz,
2 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 21.6, 42.3, 55.5
(CH2), 67.9, 69.2, 70.3 (CH2), 71.5 (CH2), 72.5 (CH2), 73.2 (CH2),
78.8, 79.4, 127.4, 127.5, 127.6, 127.7, 127.8, 128.0, 128.2 (2ϫC),
128.3, 128.4, 129.9, 135.4, 137.1, 138.3, 138.5, 144.9 ppm. HRMS
(ES+): calcd. for C35H40NO5S [M + H]+ 586.2624; found 586.2656.
Method B: Compound 17 (0.040 g, 0.069 mmol) was converted to
18 (0.023 g, 57%) by following the procedure described for the
preparation of 7 (Method B).
(400 MHz, CDCl3): δ = 2.26 (dd, J = 9.6, 12.8 Hz, 1 H), 2.44 (s, 3
H), 2.75 (dd, J = 8.4, 12.8 Hz, 1 H), 3.00 (dd, J = 5.6, 10.4 Hz, 1
H), 3.27 (s, 3 H), 3.42 (dd, J = 4.4, 10.8 Hz, 1 H), 3.59 (dd, J =
2.8, 10.8 Hz, 1 H), 3.64–3.69 (m, 4 H), 4.04 (d, J = 12.0 Hz, 1 H),
4.29–4.33 (m, 1 H), 4.39–4.48 (m, 4 H), 4.57 (d, J = 12.0 Hz, 1 H),
4.70 (d, J = 10.4 Hz, 1 H), 7.18 (d, J = 6.4 Hz, 2 H), 7.19–7.39 (m,
15 H), 7.77 (d, J = 8.4 Hz, 2 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 21.6, 36.1 (CH2), 52.3, 52.4, 55.4, 60.8, 68.3, 70.1
(CH2), 70.2 (CH2), 72.5 (CH2), 73.4 (CH2), 75.8, 77.8, 127.3, 127.5,
127.6 (2ϫC), 127.9, 128.0, 128.2, 128.3, 128.4, 128.6, 130.0, 134.7,
137.3, 138.1, 138.6, 145.1, 169.9, 170.7 ppm. HRMS (ES+): calcd.
for C39H42O9SNa [M + Na]+ 709.2447; found 709.2444.
Compound 15: Compound 13 (0.20 g, 0.308 mmol) was converted
to 15 (0.13 g, 62%) by following the procedure described for the
preparation of 4. Colorless oil, [α]2D7 = +30.4 (c = 0.20, CHCl3). 1H
NMR (400 MHz, CDCl3): δ = 0.94 (t, J = 7.2 Hz, 3 H), 1.18 (t, J
= 7.2 Hz, 3 H), 2.22 (dd, J = 9.6, 12.8 Hz, 1 H), 2.43 (s, 3 H), 2.78
(dd, J = 8.4, 12.8 Hz, 1 H), 2.97 (dd, J = 5.6, 10.4 Hz, 1 H), 3.40
(dd, J = 4.4, 10.4 Hz, 1 H), 3.57 (dd, J = 2.8, 10.8 Hz, 1 H), 3.56–
3.78 (m, 3 H), 4.05–4.21 (m, 3 H), 4.31–4.55 (m, 6 H), 4.68 (d, J
= 10.4 Hz, 1 H), 7.17–7.35 (m, 17 H), 7.77 (d, J = 8.0 Hz, 2 H)
ppm. 13C NMR (100 MHz, CDCl3): δ = 13.5, 14.0, 21.6, 36.2
(CH2), 54.9, 60.9, 61.4 (CH2), 68.4, 70.1 (CH2), 72.2 (CH2), 73.3
(CH2), 75.9, 78.0, 127.2, 127.6, 127.8, 127.9, 128.1, 128.4, 128.6,
130.0, 134.6, 137.3, 138.1, 138.8, 145.0, 169.5, 170.2 ppm. HRMS
(ES+): calcd. for C41H46O9SNa [M + Na]+ 737.2760; found
737.2760.
Compound 19: Method A: Compound 13 (0.225 g, 0.34 mmol) was
converted to 19 (0.174 g, 76%) by following the procedure de-
scribed for the preparation of 8. Semisolid, [α]2D4 = –41.6 (c = 0.09,
1
CHCl3). H NMR (400 MHz, CDCl3): δ = 2.39 (s, 3 H), 2.72 (dd,
J = 4.0, 7.2 Hz, 1 H), 3.17–3.27 (m, 2 H), 3.49 (d, J = 13.2 Hz, 1
H), 3.64–3.74 (m, 2 H), 3.80–3.85 (m, 1 H), 3.89–3.93 (m, 1 H), 4.0
(d, J = 13.2 Hz, 1 H), 4.33–4.39 (m, 4 H), 4.50–4.53 (m, 2 H), 4.69
(d, J = 11.2 Hz, 1 H), 7.09–7.11 (m, 2 H), 7.20–7.32 (m, 20 H),
7.37 (d, J = 4.4 Hz, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
21.6, 51.9 (CH2), 60.1 (CH2), 67.2, 68.9, 70.7 (CH2), 72.4 (CH2),
73.0 (CH2), 73.2 (CH2), 78.6, 79.5, 127.0, 127.4, 127.6
(2ϫC),127.7, 127.8 (2ϫC), 127.9, 128.0 (2ϫC), 128.1 (2ϫC),
128.2 (2ϫC), 128.3 (2ϫC), 128.5 (2ϫC), 128.6, 128.8, 129.8,
135.7, 137.4, 138.3, 138.7, 138.8, 144.7 ppm. HRMS (ES+): calcd.
for C41H44NO5S [M + H]+ 662.2940; found 662.2934. Method B:
Compound 17 (0.03 g, 0.047 mmol) was converted to 19 (0.018 g,
51%) by following the procedure described for the preparation of
8 (Method B).
Compound 16: Compound 13 (0.20 g, 0.308 mmol) was converted
to 16 (0.13 g, 62%) by following the procedure described for the
preparation of 5 without DMSO treatment. White solid, m.p
135 °C, [α]2D7 = +61.0 (c = 0.20, CHCl ). IR (CHCl ): ν = 1086,
Compound 20: Compound 13 (0.20 g, 0.308 mmol) was converted
˜
3
3
1190, 1304, 1317, 1454, 1597, 2253, 2365 cm–1. 1H NMR
to 20 (0.168 g, 83%) by following the procedure described for the
1
(400 MHz, CDCl3): δ = 2.48 (s, 3 H), 2.57 (q, J = 7.6, 13.2 Hz, 1 preparation of 9. Colorless oil, [α]2D7 = –4.2 (c = 0.53, CHCl3). H
H), 2.86 (m, 1 H), 2.97 (m, 1 H), 3.36 (t, J = 12.8 Hz, 1 H), 3.48– NMR (400 MHz, CDCl3): δ = 2.39 (s, 3 H), 2.86 (dd, J = 7.6,
3.50 (m, 2 H), 3.96 (d, J = 9.6 Hz, 1 H), 4.34 (d, J = 12.0 Hz, 1
H), 4.45–4.53 (m, 3 H), 4.61 (q, J = 10.8, 21.6 Hz, 2 H), 5.08 (d, J = 14.4 Hz, 1 H), 3.87–3.95 (m, 2 H), 4.16 (d, J = 14.4 Hz, 1 H),
= 11.6 Hz, 1 H), 7.26–7.39 (m, 17 H), 7.75 (d, J = 7.6 Hz, 2 H) 4.36–4.43 (m, 4 H), 4.48–4.55 (m, 2 H), 4.69 (d, J = 11.2 Hz, 1 H),
ppm. 13C NMR (100 MHz, CDCl3): δ = 21.7, 34.6, 38.0 (CH2), 7.10–7.15 (m, 3 H), 7.24–7.33 (m, 16 H), 7.55–7.60 (m, 1 H), 7.69
11.2 Hz, 1 H), 3.29–3.37 (m, 2 H), 3.61–3.68 (m, 2 H), 3.76 (d, J
878
www.eurjoc.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2010, 872–881